Goldman Sachs Initiates Coverage On Elanco Animal Health with Buy Rating, Announces Price Target of $32

Goldman Sachs analyst Matt Dellatorre has initiated coverage on Elanco Animal Health (NYSE: ELAN) with a Buy rating. The firm has set a price target of $32 for the company's stock.